This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pfizer Corporation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Ujjwal Chaitanya Joshi: Innovator in Therapeutic Nanoparticle Technology
Introduction
Ujjwal Chaitanya Joshi is an accomplished inventor based in Arlington, MA, who has made significant contributions to the field of therapeutic nanoparticles. His innovative work focuses on developing advanced delivery systems for therapeutic agents. With one patented invention, he is making strides in enhancing the efficacy of medical treatments.
Latest Patents
Ujjwal holds a patent for "Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same." This patent encompasses nanoparticles that include an endo-lysosomal escape agent, a nucleic acid, and a polymer. The disclosed technology has potential applications in improving drug delivery systems, thereby advancing therapeutic options in various medical treatments.
Career Highlights
Ujjwal is currently employed at Pfizer Corporation, a leading biopharmaceutical company. His expertise in nanoparticle technology and dedication to research has contributed to the innovative atmosphere at Pfizer, where ground-breaking work in medicine is always a priority.
Collaborations
During his career, Ujjwal has worked alongside notable colleagues such as Allen Thomas Horhota and Young-Ho Song. These collaborations enhance the innovative landscape of research at Pfizer, leading to novel inventions and advancements in medicine.
Conclusion
Ujjwal Chaitanya Joshi is a notable figure in the realm of therapeutic nanoparticle research. His patented invention and collaboration with other experts in the field position him as an important contributor to modern pharmacological advancements. Through his work, he continues to pave the way for future innovations, enhancing the potential for effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
